MEDINTEL

Welcome to the Brand page for “MEDINTEL”, which is offered here for Med intel;medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomes;.

Its status is currently believed to be active. Its class is unavailable. “MEDINTEL” is believed to be currently owned by “MILLENNIUM HEALTH LLC”.


Owner:
MILLENNIUM HEALTH LLC
Owner Details
Description:
MED INTEL;Medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomes;
Categories: MED INTEL